SEARCH RESULTS FOR: "Tag: ARIA"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2017(2)
2016(17)
2015(17)
2014(2)
CATEGORIES
Analyst Downgrades(2)
Analyst Update(1)
Analyst Upgrades(1)
Buzz Stocks(4)
Earnings Preview(1)
Expectational Analysis(1)
Ezines(1)
General(8)
Intraday Option Activity(7)
Market Recap(1)
Midday Market Check(2)
Stock Market News(11)
Stocks On the Move(10)
The Week Ahead(1)

1/9/2017 12:51 PM
The SPDR S&P Biotech (ETF) (NYSE:XBI) is on pace to end in the black for the fifth day straight, currently trading 2.4% higher at $64.86. Several notable biotech movers-- including Ariad Pharmaceutic...
1/9/2017 9:27 AM
Futures on the Dow are pointing to a lower start for the day, with a number of Fed speeches on tap. Among specific equities in the spotlight are molecular diagnostics firm EXACT Sciences Corporation ...
11/29/2016 9:10 AM
U.S. stock futures are signaling a solid start, following an upbeat gross domestic product (GDP) reading. Among specific equities in focus today are drugmaker Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA...
11/7/2016 11:37 AM
While this earnings season is past its peak, there are still plenty of results filing in this week. Among the names kicking off the earnings reactions today are biotech firms Ariad Pharmaceuticals, I...
11/4/2016 12:24 PM
Earnings season has resulted in some sharp moves for biotech stocks. For that reason, it's worth noting next Monday boasts a deep lineup of drugmakers ready to enter the earnings confessional. Among ...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center